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Abstract
We have developed a low-cost molecularly imprinted polymer (MIP)-based fluorometric assay to
directly quantify myoglobin in a biological sample. The assay uses a previously unreported method for
the development of microwave-assisted rapid synthesis of aldehyde functionalized magnetic
nanoparticles, in just 20min. The aldehyde functionalized nanoparticles have an average size of 7.5
nm±1.8 and saturation magnetizations of 31.8 emu g−1 with near-closed magnetization loops,
confirming their superparamagnetic properties. We have subsequently shown that protein tethering
was possible to the aldehyde particles, with 0.25±0.013 mg of myoglobin adsorbed to 20 mg of the
nanomaterial. Myoglobin-specific fluorescently tagged MIP (F-MIP) particles were synthesized and
used within the assay to capture myoglobin from a test sample. Excess F-MIP was removed from the
sample using protein functionalized magnetic nanoparticles (Mb-SPION), with the remaining sample
analyzed using fluorescence spectroscopy. The obtained calibration plot of myoglobin showed a linear
correlation ranging from 60 pg ml−1 to 6 mg ml−1 with the limit of detection of 60 pg ml−1. This
method was successfully used to detect myoglobin in spiked fetal calf serum, with a recovery rate of
more than 93%.
Supplementary material for this article is available online
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Introduction
A biomarker is a characteristic that is accurately measured
and evaluated as an indicator of normal biological processes,
pathogenic processes, or pharmacologic responses to a ther-
apeutic intervention [1]. They are usually measured from
tissue biopsies or liquid (blood, saliva, and urine). Biomarkers
are critical to the development of drug delivery and medical
devices [2] and are currently being used in research and
clinical practice for:
• Diagnosing diseases or predicting risks of diseases.
• Monitoring healthy people to detect early signs of a
disease.
• Determining whether a treatment is efficient or not.
• Targeting groups of people for whom a certain drug may
be useful.
• Producing safer drugs by predicting the potential adverse
effects earlier [3, 4].
Traditional biomarkers of myocardial necrosis are cardiac
enzymes (kinase), myoglobin (Mb) and troponin [5–7].
Myoglobin is the earliest biomarker to appear, following
acute myocardial infarction (AMI) [8]. It is an important
oxygen carrying monomeric heme-protein that is found in
heart and skeletal muscles, with its main function being the
uptake of oxygen from oxyhemoglobin in the bloodstream
[9]. When muscle cells are damaged Mb is rapidly released
into blood circulation. Mb that is determined in serum can be
used as an important biomarker for cardiac injury [10]. The
normal range of Mb present in the serum of healthy patients is
usually between 0 and 85 ng ml−1 [11]. The concentration of
Mb within serum can quickly become elevated in as little as
one hour after AMI and this correlates with the degree of
myocardial injury [12, 13]. Current clinical practises use
immunoassays, for the detection of AMI biomarkers in blood
serum, which have relatively low accuracy and sensitivity,
making the monitoring of disease treatment difficult. Work by
Zaninotto, et al show that the BNA and OPUS assay have
relatively high imprecision (>7.4%), as does the Access assay
(6.0%–11.0%) [14]. There is, therefore scope for the devel-
opment of new and more accurate assays and diagnostics.
Fluorescence assays, work by measuring emission
intensity generated from a sample, the emission intensity
being directly proportional to the concentration of the fluor-
ophore present [15]. A typical method used for biomarker
detection in solution is to use a heterogeneous non-competi-
tive assay. This is when the analyte, within the sample, binds
with labeled capture molecules. Leftover unbound labeled
capture molecules are then removed and then the remaining
bound labeled capture molecules are measured. The intensity
of the signal is directly proportional to the concentration of a
known analyte [16]. Fluorescence methods are one of the
most widespread label-based approaches used in biomarker
detection [17]. This is because of the availability of many
fluorescent probes with diverse spectral properties, use of
visible light, and rapid detection and signal generation.
Affinity-based methods (immunoassays and hybridization
assays) that rely on the ability of biomolecules (antibodies
and nucleic acids) to specifically recognize and bind to target
molecules, are used in conjunction with label-based bio-
marker detection [18]. While, being well-established and
highly efficient, this diagnostic method routinely uses anti-
bodies and enzymes, because of their sensitivity and affinity.
Unfortunately, they still suffer from short shelf-life, high
manufacturing cost and relatively poor stability (especially in
organic solvents, and at extreme temperature and pH values)
[19]. Additionally, it can often be difficult to immobilize
antibodies on to the supports that are currently being used in
diagnostic assays [20].
In order for a diagnostic test to be efficient, parameters
such as specificity, cost, limits of detection (LOD) and analysis
time are very important [21]. As an alternative to the antibody
approach, molecularly imprinted polymers (MIPs) have been
used in non-competitive assays and biosensors, essentially as
capture molecules. Molecular imprinting is a technique used to
synthesize template-shaped cavities within a polymer matrix
with affinity to a chosen ‘template’ molecule. The process
involves initiating the polymerization of monomers in the pre-
sence of a template molecule [22–24]. The template is then
extracted, leaving a polymer with an affinity for the original
template molecule [25, 26]. While MIPs may currently lack
sensitivity for efficient application for early disease diagnosis
they can be employed in the screening and monitoring stages of
a disease [27]. MIP-based biosensors have been reported for
protein biomarkers, including PSA, alpha-fetoprotein (AFP),
and carcinoembryonic antigen (CEA), with lower detection
limits of 9.6×10–3, 1.25×10–3, and 8 ng ml−1, respectively
[28–30]. Erturk et al showed that while these LODs are good,
they are yet to compete with similar, antibody-based assays
suggesting there is possibility for improvement [28]. The use of
the whole protein as a template will increase the accuracy of the
MIP, although the same imprinted sites formed for these larger
structures could potentially be attractive sites for similar sized or
smaller protein binding (due to other proteins native to a blood
sample), leading to unwanted cross-reactivity and reduced
selectivity [31]. When compared with the current protein
detection methods (electrochemistry, ELISA, SPR, and colori-
metric and fluorescence assays), significant advances still need
to be made with MIP-based sensors, with regards to the sen-
sitivity, selectivity and the capacity for multi-analyte detection
[21, 31]. Fluorescence materials can be incorporated into sen-
sors and fluorescence tagged MIP-based sensors offer a con-
venient solution due to increased sensitivity and selectivity,
while also offering many advantages such as short analysis
time, ease of use and small sample volume [32]. Adding a
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fluorescent monomer during MIP synthesis is potentially an
easy way to prepare a fluorescent MIP (F-MIP). For example,
Ashley et al (2018) used fluorescein-O-acrylate as the fluor-
escent tag, with fluorescent quenching used in the detection of
low molecular weight doxycycline [27, 33]. This suggests that
using a fluorescent tag with a MIP imprinted for a biomarker
could be a successful approach.
Superparamagnetic iron oxide nanoparticles (SPIONs)
are particles of iron oxide with a diameter between 1 and 100
nm [34, 35] and are available in the two main forms of:
magnetite (Fe3O4) and maghemite (γ-Fe2O3). They are cre-
ated when ferrimagnetic, multidomain samples of iron oxide
(Fe3O4 and γ-Fe2O3) particles are reduced to sizes less than
around 100 nm [35]. SPIONs are able to show robust para-
magnetic nature, with high sensitivity under the appliance of a
magnetic field and complete disappearance of that nature once
the magnetic field is removed; thus, removing any chance of
magnetic remanence and coercivity. Due to their super-
paramagnetic properties and potential non-toxicity to humans,
there has been an extensive amount of interest in the use and
synthesis of SPIONs, especially within biological and med-
icinal applications. For biomedical applications these include
magnetic resonance imaging, magnetic fluid hyperthermia,
bioseparation (DNA, proteins and cells), biomolecule immo-
bilization, and magnetic targeted drug delivery; amongst
others [36–45]. SPIONs offer essential properties including
magnetic susceptibility, low cytotoxicity, good biocompat-
ibility, and stability under physiological environments [46].
In order for SPIONs to interact with bioactive substances,
they are usually functionalized with a reactive group, typi-
cally amino (–NH2), aldehyde (–CHO) or carboxylic acid (–
COOH) [47, 48]. These modified SPIONs can be used to bind
to biomolecules, such as proteins, through non-covalent
(hydrogen bonding) interactions but primarily through cova-
lent linkages [47, 48]. They are preferred for use in biome-
dicine as they are biocompatible and potentially non-toxic to
humans [46]. Iron oxide is easily degradable and can there-
fore be useful when used for in vivo applications [49] such as
cancer magnetic therapy [50, 51]. Here the iron oxide nano-
particles are loaded with antitumor drugs and remotely
directed via an external magnetic field. This allows for more
accurate, localized targeting systems, as well as further
enhancing the antitumor activity by moderate magnetic
hyperthermia (below 40 °C) [40].
There have been several different methods used to pro-
duce SPIONs of a controlled size and shape with solvother-
mal methods proving particularly successful [52, 53].
However, solvothermal methods can be multi-step processes
and time consuming (>8 h), producing only small yields of
functionalized particles [48, 54, 55]. Recently, there has been
a surge in interest in the application of microwave radiation as
a thermodynamic driving force, with the prospect of devel-
oping environmentally conscious, simple and time efficient
routes towards the synthesis of nanomaterials [56].
In this paper a heterogeneous non-competitive assay was
developed for the detection of the AMI biomarker myoglobin.
A F-MIP was created for the target molecule (myoglobin),
with this MIP being used as a capture molecule within an
assay for Mb. Previous work showed that acrylamide was an
effective monomer to use within a MIP for myoglobin,
because the monomer is water soluble, produces excellent
rebinding, with minimal effect on the secondary structure of
the protein [57]. The fluorescent monomer, fluorescein O-
acrylate was chemically bound during myoglobin MIP
synthesis to allow for fluorescence spectroscopy detection.
The resulting F-MIP was added to a sample containing the
target molecule, whereby the target molecule would bind to
the MIP. Excess MIP would then be removed by the addition
of myoglobin modified SPIONs, synthesized using a pre-
viously unreported microwave-assisted one-step 20 min
synthesis. These particles would essentially bind to any
excess MIP, which could then be separated using a magnet
leaving only the target protein bound MIPs in suspension.
The F-MIPs in suspension (bound to target protein) were then
analyzed using fluorescence spectroscopy, whereby the
intensity of the signal is proportional to the amount of target




acrylamide (AAm), ammonium persulphate (APS), anhydrous
sodium acetate (NaOAc), bovine serum albumin (BSA) ethanol,
ethyl acetate, ethylene glycol, ferric chloride hexahydrate
(FeCl3·6H2O), fetal calf serum (FCS), fluorescein O-acrylate,
glacial acetic acid (AcOH), glutaraldehyde, myoglobin (Mb)
(from equine skeletal muscle), N N, N′-methylenebisacrylamide
(mBAm), phosphate buffered saline (PBS), sodium dodecyl
sulfate (SDS), tetramethylethyldiamide (TEMED), were all
purchased and used without purification from Sigma-Aldrich,
Poole, Dorset, UK.
Instrumentation
BioDrop μLITE UV/visible spectrometer was purchased from
Biochrom Ltd Cambridge, UK. Horiba JY FluorMax – 4 spec-
trofluorometer was purchased from Horiba UK Limited, North-
ampton, UK. The 6 kOe vibrating sample magnetometer (VSM)
was built in-house at the University of Central Lancashire, Pre-
ston, UK. Nicolet AVATAR 330 FTIR spectrophotometer with
Pike MIRacle accessory and FEI Tecnai 12 TEM at 100 kV with
a Tietz F214 2k× 2k CCD camera were purchased from Thermo
Fisher Scientific, Loughborough, UK. Bruker D2 Phaser Bench
top X-ray diffractometer was purchased from Bruker UK Lim-
ited, Coventry, UK. Anton Paar monowave 200 microwave oven
was purchased from Anton Paar Ltd Hertfordshire, UK. SLS Lab
basics centrifuge was purchased from Scientific Laboratory
Supplies, Nottingham, UK.
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Methods
Synthesis of fluorophore tagged MIPs
Solution preparation. A solution of 10% (w/v):10% (v/v)
SDS:AcOH was prepared for use in the washing (protein
elution) stages before the template reloading stage. SDS (10
g) and AcOH (10 ml) was dissolved in 990 ml of deionised
(DI) water, to produce 1 l of the washing solution.
MIP preparation. Bulk MIP hydrogels were produced, using
an optimized methodology [58], where a 10% cross-linking
monomer/N,N′-methylenebisacrylamide hydrogel was found
to produce the optimal imprint for Mb, in terms of specificity
and rebinding efficiency of the MIP, compared with the non-
imprinted polymer (NIP) [58].
Fluorescein MIP synthesis. Into an Eppendorf tube, 12 mg
of myoglobin template was dissolved in 435 μl of deionised
water vortexed for 1 min, followed by the addition of 135 μl
(7.6×10–4 mol) of 40% AAm solution, 300 μl (3.9×10–5
mol) mBAm (cross-linker), and 100 μl of 1×10–3 mMol
fluorescein O-acrylate solution (monomer: crosslinker:
f-monomer molar ratio was 760:39:1), then vortexed for a
further minute). Finally, 10 μl of a 5% TEMED (v/v) solution
and 20 μl 5% APS (w/v) solution were added and the mixture
was vortexed for 1 min. Solutions were purged with nitrogen
for 5 min and polymerization occurred overnight at room
temperature (∼20 °C). Corresponding NIPs were produced
using the same method, but in the absence of a protein
template.
After polymerization, the gels were granulated sepa-
rately, using a 35 μm sieve. The refined gels were washed
with five 1 ml volumes of deionised water followed by five 1
ml volumes of 10% (w/v):10% (v/v) SDS:AcOH eluent; this
allowed for the removal of the template protein from the MIP
cavities. Following this, the gels were washed with five 1 ml
volumes of deionised water to remove all residual 10% (w/
v):10% (v/v) SDS:AcOH from the MIP gels. Each wash step
was followed by centrifugation, whereby the gels were
vortexed then centrifuged (using SLS Lab Basics centrifuge)
for 5 min at 15 000 rpm (RCF: 15 100× g). Corresponding
NIPs were synthesized using the same procedure as the MIPs,
but in the absence of the template molecule.
MIP rebinding studies. The subsequent protein rebinding
ability of the conditioned and equilibrated MIPs and NIPs
were characterized using the BioDrop μLITE UV/visible
spectrometer. Hydrogels (200 mg) were then each treated
with 400 μl of a 3 mg ml−1 myoglobin (template protein)
solution. The polymer/protein solutions were mixed on a
rotary vortex mixer and allowed to associate at room
temperature (∼20 °C), then washed four times with 1 ml of
deionized water. Each reload and wash step for hydrogels was
followed by centrifugation for 5 min at 15 000 rpm (RCF:
15 100×g). All supernatants were collected for analysis by
spectrophotometry (at 405 nm for myoglobin).
Selectivity studies were performed on the MIP using the
protein, bovine serum album (BSA). This performed using the
previous method, but substituting the 400 μl of a 3 mg ml−1
myoglobin (template protein) solution, with a 400 μl of a 3
mg ml−1 bovine serum albumin (non-template protein)
solution.
Myoglobin functionalized SPIONs
Preparation of functionalized SPION. The functionalized
SPIONs were prepared through a one-pot solvothermal
microwave method. FeCl3ˑ6H2O was used as a single iron
source and glutaraldehyde as a modification ligand. With
stirring, 0.5 g of FeCl3ˑ6H2O and 1.8 g of NaOAc were
dissolved in 15 ml of ethylene glycol in a 30 ml Anton Parr
G30 microwave reaction vial (MRV). The functionalization
agent (glutaraldehyde (3.5 ml) was then added to the resulting
solution and stirring continued for a further 5 min. The
magnetic stirrer bar was then removed and the MRV was
placed into an Anton Paar monowave 200 microwave oven
and the reaction was heated up to a temperature of 200 °C
with a ramp time of 2 min. The reaction was held at 200 °C
for 20 min under pressure (9 bar). The resulting composite
products were washed five times with deionised water
followed by two washes of ethanol, and then collected with
a magnet and finally dried for further use. The method was
repeated, but in the absence of a functionalization agent, to
produce bare SPIONs.
Protein conjugation to functionalized SPION. The protein
adsorption capacity of the obtained magnetic particles was
investigated using Mb as the model protein. Five Mb
solutions of 0.2, 0.3, 0.4, 0.5, 0.6 mg ml−1 were prepared
and 1 ml of each protein solution was added to 20 mg of the
magnetic material. The mixture was vortexed followed by
shaking. We determined that the optimum time for this step
was 30 min. Afterwards, the mixture was then centrifuged
(SLS Lab basics centrifuge) for 5 min at 15 000 rpm (RCF:
15 100×g). The amount of protein adsorbed onto the
SPIONs (functionalized and bare) was calculated through
comparing the initial and final concentrations of protein
remaining in the supernatant. The concentration of the non-
adsorbed protein was measured by spectrophotometry (405
nm for Mb) using a BioDrop μLITE UV/visible
spectrometer.
SPION characterization. Functionalized nanoparticles were
suspended in ultra-pure water (0.1 g in 50 μl water) and a 5
μl droplet was deposited onto a Formvar/carbon coated 200
mesh copper TEM grid (Agar Scientific, UK). After 1 min the
grid was blotted, washed for 30 s in ultra-pure water, blotted
again and allowed to dry. Images were collected using a FEI
Tecnai 12 TEM at 100 kV with a Tietz F214 2k × 2k CCD
camera. Fourier transform infrared (FTIR) spectra were
obtained on a Nicolet AVATAR 330 FTIR spectrophotometer
fitted with a Pike MIRacle accessory. The FTIR was recorded
using transmission mode and the spectrum was collected at
room temperature in 4000–400 cm−1 region with a resolution of
4 cm−1 using 32 scans. The crystal structure information was
recorded using a Bruker D2 Phaser Bench top x-ray
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diffractometer system equipped with a LynxEye detector and
using Cu Kα12 radiation (λ=1.5418 Å). Data were collected
between 5° and 80° 2-theta using a step size of 0.02019°.
Pawley fits were performed using the TOPAS program. Initial
lattice parameters for ETS-10 and quartz were taken from
Anderson et al [59] and le Page and Donnay [60], respectively.
A 12-term Chebyshev background function and a pseudo-
Voight peak profile function were all used for refinements.
Magnetization curves were measured at room temperature using
an in-house 6 kOe VSM. The samples were first crushed with a
pestle and mortar, to break-up the large agglomerations of the
dry state. This enabled them to be packed into rectangular glass
microslides (Camlab) of internal dimensions 0.40±0.04 mm
by 4.0±0.1 mm that were cut in lengths of 10.5±0.5 mm. In
this geometry the demagnetization factor (N), was kept low and
within the range 0.030<N<0.068 [61].
F-MIP assay. A MIP-based non-competitive assay was
designed for the detection of the AMI biomarker
myoglobin. The assay uses an excess amount of F-MIP as a
capture molecule, to bind to all of the myoglobin within the
sample. Mb-SPIONs were then used to bind to all the
remaining unbound MIP, which was then subsequently
removed with magnetism. The MIP left in the sample was
then removed and analyzed using fluorescent spectroscopy,
with fluorescent intensity directly related to the amount of
myoglobin in the sample.
Non-competitive assay calibration. Solutions containing
known concentrations of Mb (6, 0.6, 6×10–2, 6×10–3,
6×10–4, 6×10–5, 6×10–6, 6×10–7, 6×10–8, and
6×10–9 mg) were prepared in 1 ml of PBS, followed by the
addition of 100 mg of F-MIP/NIP to the sample. This was then
vortexed for 30 s and left for 5 min to allow the protein to
associate with the imprinted or non-imprinted gel. Next, 30 mg
(optimum amount) of Mb-SPION was added, followed by
further vortexing (30 s) and protein association (5min). MIP/
NIP particles bound to the Mb-SPION were removed using a
magnet, and the supernatant then analyzed using a Horiba JY
FluorMax – 4 spectrofluorometer with an excitation at 490 nm
and an emission scan range of 200–900 nm. A calibration curve
was created by plotting the log of the amount of protein loaded
(mg ml−1) versus log intensity (CPS). The calibration was
repeated, but with FCS used instead of PBS.
To test the assay, 1 ml samples of FCS were spiked with
known concentrations of Mb (10, 80 and 160 ng ml−1). These
values were chosen because it would allow for the detection
of Mb within the normal range of healthy patients, as well as
showing the range on and above the borderline for elevated
levels (above 85 ng ml−1) seen in patients [11]. Next, 100 mg
of F-MIP/NIP was added to the sample and vortexed for 30 s
and left for 5 min to allow the protein to associate with the
imprinted gel. Next, 30 mg (optimum amount) of Mb-SPION
was added, followed by further vortexing (30 s) and protein
association (5 min). MIP particles bound to the Mb-SPION
were removed using a magnet, and the supernatant then
analyzed using fluorescence spectroscopy with excitation at
490 nm and an emission scan range of 200–900 nm. The
results were compared with the calibration plot in order to
evaluate the error within the assay.
Results and discussion
MIP synthesis and rebinding studies
Fluorophoric MIPs (F-MIPs) and their corresponding NIPs
were successfully synthesized using the optimized method
[58]. Rebinding studies were performed on these and the
results are presented in table 1. This confirmed that there was
no detrimental effect in the ability of target molecule to bind
to MIP when integrating the fluorophore into the MIP/NIP
synthesis.
Our previous work, showed that a polyacrylamide-based
MIP for the target protein myoglobin had a rebinding capacity
, of 85.4% with an IF value of 1.80, suggesting that the MIP
has a good degree of affinity with a high degree of selectivity
compared to the corresponding NIP and other acrylamide-
based functional monomers [57]. When the fluorophore was
integrated into a polyacrylamide-based MIP, the amount of
myoglobin target that rebound was 85.8%. This shows that
the fluorophore integrated MIPs produce rebinding char-
acteristics which are very similar to that of the polyacrylamide
MIP (±1.6%) [57], indicating that there is little to no effect on
rebinding of the target protein, when integrating the fluor-
ophore into the MIP. These results offered assurance that a
fluorophore integrated MIP can be used to develop a fluoro-
metric MIP-based assay for myoglobin. Table 1 also shows
that the Mb templated MIP will bind 42.4% of non-specific
BSA. This value is very similar to the binding capacity of the
NIP, confirming that the Mb MIP has selectivity towards the
target protein.
Rapid microwave-assisted synthesis of functionalized SPIONs
Microwave-assisted synthesis is based on the accelerated heat-
ing of materials due to dielectric heating effects. The microwave
energy produced is only transferred directly to those reaction
components, which are susceptible to microwave polarization.
Table 1. Percentage of the myoglobin target protein (Mb) rebind to the acrylamide-based MIP and NIP with incorporated fluorophore and the
corresponding imprinting factor as well as percentage of bovine serum albumin non-target protein (BSA) bind to MIP.
Fluorophore
MIP percentage of Mb
rebind (%)
NIP percentage of protein
bind (%) Imprinting factor (IF)
MIP percentage of BSA
bind (%)
Fluorescein O-acrylate 85.8±2.9 43.9±2.7 1.95 42.4±2.3
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This improves the energy efficiency, by only heating the reac-
tion mixture and reduces the need to heat any reaction vessels,
unlike conventional heating. As a result of this directed heating,
heating the reagents is much faster than with conventional
methods. This, in turn, minimizes the time it takes for the
reaction to reach its activation energy and can radically reduce
the reaction time, with the added benefit that this method
reduces unwanted side reactions and by-products [62].
Ethylene glycol was the solvent used in this reaction and
is known to have a high dissipation factor (tan δ=1). The
solvent has a higher capacity to absorb microwaves and
convert to thermal energy, making it ideal for microwave
synthesis [63]. Producing functionalized SPIONs by a con-
ventional solvothermal method [48] takes 480 min for the
reaction to be complete, whereas our microwave-assisted
method only takes 20 min. Different synthesis times were
trialed, before settling upon 20 min; 10 min did not yield
nanoparticles. Whereas 30 min was successful in producing
nanoparticles, we selected 20 min synthesis for further
studies.
The TEM images for SPION@CHO, and SPION (bare) are
shown in figures 1(A), and (B), respectively. The obtained
nanoparticles are nearly spherical and dispersive with a diameter,
ranging from 1.6 to 11.6 nm. The microwave method, generally
produces particles that are smaller (7.5 and 7.4 nm, for
SPION@CHO and SPION (bare) respectively) than the particles
produced using a solvothermal method (19.3 nm) [48], with a
summary of all the particles shown in table 2. The
SPION@CHO (figure 1(A)) appears to show small agglomer-
ates of SPIONs embedded within a polymeric matrix, which
could account for the larger size of the individual particles within
each agglomerate. The bare SPIONs (figure 1(B)) shows parti-
cles that appear consistently spherical shape and similar in size.
The FTIR spectra of the functionalized SPIONs are
shown in figures 2(A) and (B), where the main functional groups
of the predicted structure can be observed. Figure 2(A) shows the
FTIR spectrum for the aldehyde functionalized SPION
(SPION@CHO). The absorption band at 520 cm−1 is assigned to
the Fe–O stretching vibration. The peak at 1635 cm−1 is assigned
to the stretching vibration of carbonyl, while the typical peak at
Figure 1. TEM images of SPION@CHO (A) and SPION (bare) (B). Images were collected using a FEI Tecnai 12 TEM at 100 kV with a
Tietz F214 2k × 2k CCD camera.
Figure 2. FTIR spectra of SPION@CHO (A), and SPION (bare) (B), obtained using a Nicolet AVATAR 330 FTIR spectrophotometer fitted
with a Pike MIRacle accessory.
Table 2. A comparison for the reaction methods to produce functionalized SPION between a conventional solvothermal method versus our
microwave method.
Reaction time (min) Average particle size (nm) Standard deviation (nm)
Solvothermal method [48] 480 19.3 1.8
Microwave method (CHO) 20 7.5 1.8
Microwave method (bare) 20 7.4 1.4
6
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2956 cm−1 is due to the asymmetric stretching of C–H vibration.
These characteristic peaks indicate that iron oxide magnetic
particles containing aldehyde groups on the surface have been
obtained through our one-pot microwave facilitated solvothermal
method [48]. Figure 3(B) shows an absence of any functional
groups peaks, with the only peak observed being the absorption
band at 538 cm−1, which is assigned to the Fe–O stretching
vibration. The absence of any other peaks again highlights that
fuctionalization has taken place in figure 2(A).
The XRD patterns for the synthesized SPIONs and func-
tionalized SPIONs produce the same six strong diffraction
peaks, which is to be expected as XRD only determines the
atomic and molecular structure of a crystal and does not include
any information on the functionalization. These XRD patterns
are illustrated in figure 3, where the six strong diffraction peaks
for the sample are observed in the 2θ range of 20°–80°, which
are indexed as (220), (311), (400), (422), (511), and (440),
respectively. Figures 3(A) and (B) can be seen to be very similar
in nature and this is shown in the analysis of the XRD data. The
crystallite size of the of the SPIONs was estimated using the
Scherrer equation (equation (1)), which relates the crystallite size








where, Dp is the average crystallite size, K is the Scherrer
constant (0.94), β311 is line broadening (full-width at half
maximum, in radians) and θ311 is the Bragg angle (radian).
The estimated crystallite sizes for the Fe3O4 NPs are
7.47 nm and 7.45 nm for the SPION@CHO and SPION
(bare), respectively, and is consistent with the size estimates
using TEM (table 2). The lattice parameters ‘a’ were
determined to be 8.3656 and 8.3547 for the SPION@CHO
and SPION (bare), respectively, with these values being
similar to those found in literature (a=8.399) [66]. These
results are consistent with iron oxide found in the inorganic
crystal structure database (ICSD Collection Code 5247) [67], and
confirms that we have produced Fe3O4 (magnetite) [68, 69].
The magnetic properties of the functionalized SPIONs were
studied using a VSM at room temperature (figures 4(A) and (B)).
The magnetization curves with S-like shape are symmetrical to
the origin and there is near-zero hysteresis, with both remanence
and coercivity approximately zero, indicating that the samples are
predominantly superparamagnetic. The saturation magnetization
values of 38 emu g−1 (SPION@CHO) and 75 emu g−1 (SPION
(bare)) are lower than the ferrimagnetic bulk value of 92 emu g−1
[70] and is expected when in a superparamagnetic state at particle
sizes<100 nm, as is the case here [71]. However, the values are
still high enough for easy and rapid separation when under an
external magnetic field. The TEM image of the functionalized
SPIONs (figure 2(A)) shows the magnetic particles are dis-
tributed within the nonmagnetic functionalized material and
hence this dilutes the magnetic content fraction within the sample
volume when compared to the bare SPIONs and will contribute
to the lower saturation magnetization value observed [72].
Figure 3. XRD pattern of SPION@CHO (A) and SPION (bare) (B), obtained using a Bruker D2 Phaser Bench top x-ray diffractometer
system equipped with a LynxEye detector and using Cu Kα12 radiation (λ=1.5418 Å).
Figure 4. VSM spectra of SPION@CHO (A) and SPION (bare) (B), measured at room temperature using an in-house 6 kOe Vibrating
Sample Magnetometer.
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We further investigated the ability of these particles to
covalently bind protein. This was with a view to use protein
tethered SPIONs in the development of our F-MIP based
protein diagnostic. Protein adsorption onto the SPION@CHO
was investigated by adding 1 ml of known concentrations of a
myoglobin solution. Prior to this, we had determined that a
minimum of 30 min was required for optimum adsorption of
0.4 mg ml−1 of protein (figure 5(A)). The results showed that
on average, 20 mg of SPION@CHO was able to adsorb
0.247±0.013 mg of myoglobin, respectively (figure 5(B)).
In contrast, binding of protein on non-functionalized SPIONs,
showed only limited protein adsorption (0.012±0.004 mg).
This suggests that the mechanism for protein attachment to
the aldehyde functionalized SPION is primarily through
covalent binding; glutaraldehyde has been used extensively in
the immobilization of proteins [73]. The high reactivity of
glutaraldehyde towards proteins is based on the presence of
several reactive residues in proteins and molecular forms of
glutaraldehyde in aqueous solution, which may lead to many
different possible reaction mechanisms, including, but not
limited to, aldol condensation or Michael-type addition [74].
Optimization of protein-SPION level for assay development
The fluorescently tagged MIP and NIP were explored using
fluorescent spectroscopy to determine if protein binding had
an effect on the fluorescent emission of the sample. As can
been seen in figure S1, in the supplementary data (available
online at stacks.iop.org/NANO/32/095502/mmedia), the
results show that the F-MIP has an emission intensity value
which is lower than that of the F-NIP. This is to be expected
as a F-MIP molecule contains cavities, resulting in less
polymer matrix within the same volume of particle (35 μm
particle), meaning there is less polymer within the F-MIP for
the light to be absorbed, therefore resulting in less photons
being emitted; consequently, lowering the emission intensity.
Polymer matrix differences between MIP and NIP were
explored in the work of Larpant et al (2019) who showed that
the MIP contained a matrix that was highly absorbent, with
strong affinity of the target molecule [75]. The resulting
changes in polymer matrix explains the changing in
absorbance, with work by Pelras et al (2017) showing
changes to a hydrogel matrix can increase transparency [76].
The fluorescence spectra (figure S2), for all concentrations of
the fluorescein O-acrylate monomer, show a peak at 482 nm,
which is due to excitation of the sample. The energy from the
emitted photon is responsible for the peak seen at 514 nm. As
the concentration of the fluorescein monomer is diluted fur-
ther the intensity of the peak at 514 nm steadily decreases as
to be expected, with the fluorescence intensity being pro-
portional to the concentration of the fluorophore.
In constructing the non-competitive MIP-based assay for
the detection of the AMI biomarker Mb, aldehyde functio-
nalized SPIONs (SPION@CHO) were used, with myoglobin
(Mb) bound to the nanoparticle (Mb-SPION). These nano-
particles are nearly spherical and dispersive with a diameter,
averaging 7.5 nm, with a saturation magnetization value of 38
emu g−1, meaning they can be easily and rapidly separated
from suspension under an external magnetic field.
The amount (30 mg) of the Mb-SPION conjugate needed
to bind to all of the F-MIP was first determined. This would
then give a value for the maximum amount of Mb-SPION
required per assay, and would simulate the situation of there
being zero target Mb in the test solution. Masses (0–50 mg) of
Mb-SPION were loaded into 1 ml of water containing 100 mg
of fluorescein O-acrylate (1×10–3 mmol) MIP. A magnet
was used to remove the F-MIP bound to the Mb-SPION
complex. Any remaining unbound MIP left in solution was
analyzed by fluorescence spectroscopy. The limiting amount
of Mb-SPION needed to bind to all of the F-MIP was
determined as the point when the measured fluorescence
emission intensity petered out and remained constant (at
about the same intensity as when measuring water only).
Figure 6 shows that as the amount of Mb-SPION is increased,
the fluorescence emission intensity of the sample decreases.
This pattern is of exponential decay resulting from an initial
rapid decrease in intensity, which steadily reaches a minimum
at and above 30 mg of Mb-SION with an intensity of 734 490
CPS, which is of similar intensity of a sample of water only. It
was determined that 30 mg of Mb-SPION was sufficient to
bind all of the F-MIP in the solution, so this amount was
selected be used within the assay.
Figure 5. Optimum adsorption time for Mb binding to 20 mg of SPION@CHO particles (A) and adsorption capacity (B) of the SPIONs.
Measured using spectrophotometry (405 nm for Mb) using a BioDrop μLITE UV/visible spectrometer.
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Non-competitive assay calibration
Using a non-competitive assay format, a calibration was
undertaken by dissolving known concentrations of target
protein Mb (6, 0.6, 6×10–2, 6×10–3, 6×10–4, 6×10–5,
6×10–6, 6×10–7, 6×10–8, and 6×10–9 mg) into FCS (1
ml). FCS was used, with known Mb concentrations dissolved,
in order to determine the selectivity and biocompatibility of
the F-MIP, investigating whether non-target molecules pre-
sent within the serum would interfere with the assay, leading
to the production of false positives. FCS contains many dif-
ferent proteins (BSA, Immunoglobulin G (IgG), fibrinogen,
transferrin, amongst others), with the main constituent being
albumin, [77]. The F-MIP was added to the sample, with the
target protein being allowed to associate with the MIP for
10 min. Next, 30 mg of Mb-SPION was added to the sample
and further associated with any unbound MIP was allowed for
10 min MIP particles bound to the Mb-SPIONs were removed
using a magnet, and the supernatant then analyzed using
fluorescence spectroscopy. Calibration plots were created by
plotting the log10 of the amount of protein loaded (mg ml
-1)
versus log10 intensity (CPS) and are shown in figure 7. The
calibration plots show that the assay has a linear range with a
lower LOD of 60 pg ml−1. This is a vastly wider range than
that needed for the detection of Mb in patient samples (0–80 ng
ml−1). That we can use this MIP-based assay to measure
protein levels down to pgml−1, makes it highly suitable for the
potential development of a suite of assays for a range of bio-
markers which require a low limit of detection including cancer
markers such as PSA (<4 ngml−1), CEA (<2.5 ng ml−1), and
AFP (<10 ng) [11, 78]. Calibrations were produced in PBS
buffer and FCS showing that the assay is specific only for the
target protein Mb and shows minimal interference from other
proteins (native to serum).
F-MIP-based assay for analysis of samples
The MIP-based assay was further tested by spiking 3×1 ml
samples of FCS with known concentrations of Mb (10, 80 and
160 ng ml−1). The results of the spike serum test are shown in
table 3.
The results in table 3 show that when FCS is spiked with
known concentrations of the AMI biomarker Mb, the MIP-
based non-competitive assay was able to detect the Mb to
within an error of 6.7%. This is an acceptable percentage error
as it is similar to the percentage error of other assays which
are commercially available and currently being used [14]. A
comparison of these assays with the one developed is shown
in table 4.
Table 4 shows that the developed MIP assay performs
slightly better (with a percentage error range of 2.2%–6.7%)
than the Access assay (with a percentage error range of
6.0–11.0). The results also show that the developed MIP
assay performs very similarly to the Hitachi (with a
percentage error range of 3.8%–5.8%) and Stratus (with a
percentage error range of 3.4–6.5). This shows that the
developed MIP assay is competitive with those that are cur-
rently on the market. All the market assays (Access, Hitachi,
and Stratus) use Mb antibodies as the capture molecule [79].
This uniquely developed MIP assay uses a fluorescence
spectroscopy for detection of myoglobin from a spiked
sample. Fluorescently tagged MIP is added to the sample
containing the target molecule, whereby the target molecule
would bind to the MIP. Excess MIP would then be removed
Figure 6.A plot showing how much Mb-SPION is needed to bind and remove all of the fluorescently tagged MIP from a 1ml 1:10 solution of
fluorescein O-acrylate (1×10–3 mMol) MIP:H2O.
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by the addition of the myoglobin modified SPIONs, produced
using the unreported microwave method that synthesized
aldehyde functionalized SPIONs in 20 min. Previous studies
synthesized these particles using non-microwave solvothermal
synthesis, by either a one-pot synthesis or multi-step synthesis,
often taking in excess of 8 h to produce [48, 52, 53]. This novel
synthesis dramatically decreases the time needed to produce
functionalized SPIONs (SPION@CHO), thus using less energy
and reagents, and making this synthesis much greener than
traditional methods. These particles would bind to the excess
MIP, which could then be separated using a magnet leaving
only the target protein bound MIPs in suspension. The F-MIPs
in suspension could then be analyzed using fluorescence
spectroscopy, where by the intensity of the signal is propor-
tional to the amount of target protein in the sample, as shown in
figure 8.
Conclusion
In this work, we have demonstrated a microwave facilitated, one-
pot solvothermal method for the synthesis of functionalized
SPIONs. This method allowed for the rapid synthesis of func-
tionalized SPIONs with time to production being reduced from
many hours to a mere 20min This significant reduction in
synthesis time, shows that functionalized SPION particles can be
produced using much less energy than previous solvothermal
synthesis methods. A non-competitive MIP-based fluorometric
assay was subsequently developed for the AMI biomarker Mb.
The assay used a fluorophore tagged MIP as a capture molecule,
binding specifically to myoglobin, enabling its detection and
quantitative analysis. Calibration of the assay was conducted in
FCS showing that the assay was specific only to the target pro-
tein. The assay has a low LOD, capable of detecting down to
60 pgml−1 of Mb, suggesting the assay would be suitable for
detection of Mb within patients where 0–80 ng ml−1 is the
normal range for Mb levels in healthy patients and elevated levels
(>80 ng ml−1) are seen in patients where AMI has occurred
Analyzing FCS spiked with known concentrations of Mb
demonstrated that our MIP-based assay can detect Mb within a
biological sample with an error range of only 2.2%–6.7%. This is
a similar range to antibody-based assay kits that are available on
the market [14] and demonstrating that our developed MIP-based
assay is able to compete with assay kits that are already available,
but at a fraction of the cost. MIP-based protein assays can be a
Figure 7. Calibration plots for the non-competitive assay, by comparing the log amount of protein loaded (mg ml−1) in fetal calf serum (FCS)
(blue) and phosphate buffered saline (PBS) (orange), with the log fluorescence emission intensity (CPS).
Table 3. Analysis of Mb spiked serum concentration using the developed non-competitive assay.
Mb spiked concentration (ng ml−1) Fluorescent emission intensity (CPS)
Amount of Mb calculated in
sample (ng) Percentage recovery (%)
10 2164570±1180 9.8 97.79
80 2782603±1125 85.0 93.66
160 2970330±1210 149.0 93.31
Table 4. A comparison of different assays available against the
developed MIP-based assay.
Assay Percentage error (%)





Data for these assay kits supplied by the work of
Zaninotto et al (2000) [14].
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real alternative to antibody-based assays with major implications
in the future development of disease diagnostics, especially in
instances where antibodies are either difficult to produce or do
not currently exist.
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